Pelthos Therapeutics Inc.
PTHS • AMEX • Stock Fundamentals
Pelthos Therapeutics Inc. is a biological products, (no disgnostic substances) company trading on AMEX, led by CEO Scott Plesha, with a market cap of $94.4M.
Market Cap$94.4M
Employees11.0
CEOScott Plesha
CountryUnited States of America
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
PTH
Pelthos Therapeutics Inc. FAQ
Common questions about Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. (PTHS) has a market capitalization of $94.4M and trades on AMEX.
Pelthos Therapeutics Inc. has approximately 11 employees.